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Introduction 
 
Inappropriate antimicrobial prescribing is a major and modifiable contributor to the spread of 
antimicrobial resistance. In the United Kingdom (UK), 79% of antibiotics are prescribed by 
general practitioners (GPs) [1], most commonly for the diagnosis of acute respiratory tract 
infection [2], including tonsillitis. 
Antibiotic treatment is indicated only for bacterial tonsillitis, the most common bacterial 
aetiology being group A Streptococcus (GAS). Current UK National Institute for Health and 
Care Excellence (NICE) guidance recommends considering an antibiotic prescription in 
children and adults with three or more Centor (tonsillar exudates, swollen tender anterior 
cervical nodes, fever, lack of cough, [4]) or four or more FeverPAIN ((Fever, Pus, rapid 
Attendance [illness ≤3 days], severe Inflammation, No cough or coryza [5]) criteria [3]. It is 
unclear whether this guidance is followed, as up to 83% patients with sore throat are 
prescribed antibiotics in some primary care practices [2], and many GPs do not use Centor or 
FeverPAIN criteria. 
 
In December 2015 and for the first time in the UK, St. George’s Hospital Pediatric Emergency 
Department (PED) implemented a nucleic acid amplification-based point-of-care test (POCT) 
for GAS, which has 98% sensitivity and specificity [6]. The aim of our study was to describe 
the pragmatic implementation of testing for GAS in pediatric tonsillitis and the association 
between test results and antibiotic prescribing at our center. 
 
Methods 
 
The Child Admission Bundle for Infection (CABIN) team, with support from PED leadership, 
disseminated an algorithm describing criteria for testing and proposed treatment of suspected 
GAS tonsillitis based on NICE guidance. It was emailed to all doctors working in PED, posted 
on PED teaching boards, and presented at PED teaching conferences, with in-person and 
email reminders throughout the data collection phase. The Alere™ i Strep A (Waltham, 
Massachusetts, USA) instrument was made available to PED clinicians. This molecular-based 
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test provides results in 8 minutes or less on an easy-to-use, small desktop platform. Staff were 
instructed to test throat swabs obtained from patients 16 years of age and younger who 
presented to St. George’s Hospital PED between December 2015 and January 2017 with 
suspected tonsillitis if enough Centor or FeverPAIN criteria were met. As part of the CABIN 2 
study [7], clinical information, including presence of Centor and FeverPAIN criteria, POCT 
results and outpatient antibiotic prescriptions, was collected on all patients in whom a rapid 
test was performed. 
 
Centor criteria were defined as: presence of tonsillar exudates, swollen tender anterior cervical 
nodes, temperature greater than 38.3°C, absence of cough. FeverPAIN criteria were defined 
as: fever reported by the carers or measured in PED, presence of pus on tonsils, fever duration 
≤ 3 days (as proxy for illness duration ≤ 3 days), documentation of tonsil inflammation, no 
cough or coryza. 
 
We performed a descriptive analysis, measured the association between GAS POCT result 
and outpatient antibiotic prescribing using an odds ratio calculation, and defined the areas 
under the receiver-operating characteristic (ROC) curves for Centor score and FeverPAIN 
score. All statistical tests were performed using the software package R (Vienna, Austria). 
 
Results 
 
A total of 339 children were tested with the Strep A POCT. Sore throat or difficulty swallowing 
was documented in 107 (32%) cases. The median age was 2.8 years. One hundred and thirty-
eight patients (45%) were female. Two hundred and eighty nine (85%) children had fever, 186 
(55%) absence of cough, 144 (42%) tonsillar exudates and 101 (30%) had cervical 
lymphadenopathy. 
 
Only 114 of 339 children (34%) fulfilled ≥ 3 Centor criteria, warranting POCT testing or empiric 
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treatment. The remaining 225 children (66%) had less than three criteria present: 8 (2%) 
fulfilled no criterion, 86 (25%) one and 133 (39%) two criteria.  
 
With regards to the FeverPAIN criteria, tonsil inflammation was documented in 256 children 
(76%), absence of cough or coryza in 253 (75%), fever duration ≤ 3 days in 204 (60%), and 
purulent tonsils in 144 (42%). Only 168 (49%) of tested patients had 4 or more criteria, 
warranting testing or empiric treatment. Three cases (1%) fulfilled no criterion, 20 (6%) one, 
58 (17%) two, and 90 (27%) three criteria. 
 
Of 282 children with ≥ 3 Centor or ≥ 4 FeverPAIN criteria, 101 (36%) had both ≥ 3 Centor and 
≥ 4 FeverPAIN criteria.  
The most commonly listed diagnoses among children who received the POCT were as follows: 
tonsillitis (43%), viral illness, not otherwise specified (14%), upper respiratory tract infection 
(13%), Influenza or Influenza-like illness (3%), and Scarlet fever (2%). The diagnosis was 
missing in 2% of cases. 
The rate of invalid results, a technical issue often related to incorrect handling of the Alere i 
Strep A, was 9% in our cohort. Figure 1 describes the flow of of participants according to group 
A Streptococcus POCT result and outpatient antibiotic prescription. Of 308 cases with a valid 
POCT result, 70 (23%) had a positive result and 107 (35%) resulted in an outpatient antibiotic 
prescription. Ninety-one percent of patients with a positive GAS POCT result were prescribed 
an antibiotic (n = 64), and 82% with a negative GAS POCT result did not receive a prescription 
(n = 195). There was no documented outpatient prescription in 6 cases with positive POCT 
result; these patients either received intravenous antibiotics or were admitted to the pediatric 
ward. Fourty-three children were prescribed an antibiotic, in most cases targeting GAS 
(penicillin), despite a negative GAS POCT result. Of 107 patients who received an antibiotic 
in this cohort, 43 (40%) had a negative GAS POCT result. 
There was a strong and significant association between POCT result and antibiotic 
prescribing: 64 of 70 (91%) children with a positive result received a prescription, compared 
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with 43 of 238 (18%) children with a negative result (odds ratio [OR] 48, 95% confidence 
interval [CI] 20–119). In contrast, the association between clinical criteria and antibiotic 
prescribing was of a lesser magnitude. It was significant for the following factors: age ≥ 3 years 
(OR 3.11, CI 1.90-5.08), ≥ 3 Centor criteria (OR 2.30, CI 1.41-3.76) and ≥ 4 FeverPAIN criteria 
(OR 1.77, CI 1.10-2.85). Patient sex was not associated with outpatient antibiotic prescribing 
(OR 0.84, CI 0.52-1.34). Neither score, as used in this cohort, performed well in the prediction 
of a positive POCT result. The area under the ROC curve was 0.62 (CI 0.53-0.69) for the 
Centor score and 0.57 (CI 0.49-0.65) for the FeverPAIN score. 
 
Discussion 
 
In our cohort, GAS POCT results were highly associated with antibiotic prescribing. Moreover, 
only 35% of children with suspected tonsillitis in this cohort were prescribed antibiotics, 
compared to 60% during the 2014–2015 winter season (CABIN 2 unpublished data). While 
case-mix could not be adjusted for, this likely reflects improved antibiotic stewardship. These 
results highlight the potential role for a rapid POCT in improving antibiotic use in pediatric 
tonsillitis cases in the UK. 
In contrast, the high proportion of cases that did not fulfil enough Centor or FeverPAIN criteria 
to justify testing or empiric antibiotic prescribing, 66% and 51% respectively, suggests these 
algorithms based on symptoms and signs were not consistently followed, and present an 
opportunity for improvement in diagnostic stewardship in this setting. 
 
Our results are consistent with other reports of a GAS POCT used to support appropriate 
antibiotic prescribing [8]. This evaluation of the pragmatic implementation of a novel diagnostic 
was coupled with a qualitative analysis describing the knowledge, attitudes and practices of 
families and clinicians to the care provided in the emergency department. It included 
questionnaires about the acceptability of POCT in this setting [9]. 
A formal cost-effectiveness analysis was not undertaken as the POCT was immediately 
8 
 
deemed too expensive by clinicians to justify long-term adoption at this center. 
 
 
A limitation of this study was the reliance on health records for documentation of Centor and 
FeverPAIN criteria. Data collection was therefore affected by the quality of clinical 
documentation, including missing data. For example, where tonsil inflammation was 
documented, it was assumed to be severe. This may have led to an overestimation of the true 
number of patients with enough criteria to warrant testing. Another example was the low 
documentation rate for sore throat, partially explained by the large proportion of young patients 
unable to verbalise symptoms and by poor documentation. Finally, POCT was performed in 
many cases despite the lack of sufficient Centor and FeverPAIN criteria, and the number of 
eligible patients who did not receive the POCT test is unknown; this raises the possibility of 
selection bias in the study. The performance of the two clinical scores in our cohort should be 
interpreted cautiously in view of these limitations. 
 
It is important to note that the Centor criteria were not designed for use in persons younger 
than 16 years [4], and were not validated in some pediatric studies [10]; the FeverPAIN criteria 
have also not been assessed in children younger than 3 years [5]. Hence, there might be 
clinical justification for clinicians to test for GAS without relying on these clinical scores.  
 
In the UK, the high performance of FeverPAIN criteria and cost of a POCT will pose a 
challenge to the widespread use of any test more expensive than a course of penicillin. In 
general practitioners’ clinics, the total ten-minute consultation time and impact on workflow 
constitute additional challenges. 
 
 
Conclusion 
 
The use of a rapid, molecular-based GAS POCT may reduce unnecessary antibiotic 
prescriptions in UK PED settings. Nonetheless, opportunities to improve diagnostic and 
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antimicrobial stewardship were identified in this evaluation of the pragmatic implementation of 
a novel diagnostic into a clinical pathway. Other factors such as acceptability, cost and impact 
on workflow are important predictors of successful implementation and need to be further 
evaluated. 
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